comparemela.com

Latest Breaking News On - On demand oral presentation - Page 1 : comparemela.com

Wren Presents Preclinical Data at AD/PD 2023 Demonstrating Potential of its First-in-Class, Small-Molecule Inhibitors of α-Synuclein Toxic Oligomers for the Treatment of Parkinson s Disease

/PRNewswire/ Wren announced today the presentation of preclinical data for its first-in-class, oral inhibitors of α-synuclein oligomer generation.

Vastra gotalands lanUnited statesBart hendersonPrnewswire wrenMary moynihanSamata pandeyInternational conference on alzheimerInternational conferenceRelated neurological disordersOn demand oral presentationProximity ligation assayWren therapeutics

vimarsana © 2020. All Rights Reserved.